| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/27/2000 | WO2000004030A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 01/27/2000 | WO2000004023A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 01/27/2000 | WO2000004013A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | WO2000003990A1 Pharmaceutical compositions comprising 2-quinolones |
| 01/27/2000 | WO2000003973A1 Diacylhydrazine derivatives as integrin inhibitors |
| 01/27/2000 | WO2000003737A2 Water-soluble drugs and methods for their production |
| 01/27/2000 | WO2000003733A1 Methods and compositions for cancer treatment |
| 01/27/2000 | WO2000003732A1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 01/27/2000 | WO2000003726A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | WO2000003718A1 Freeze-dried preparations and process for producing the same |
| 01/27/2000 | WO2000003709A1 Novel dna-cleaving antitumor agents |
| 01/27/2000 | WO2000003707A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 01/27/2000 | WO2000003706A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 01/27/2000 | WO1999063050A3 Method for preparation and in vivo administration of antigen presenting cell composition |
| 01/27/2000 | WO1999061406A3 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 01/27/2000 | WO1999061064A8 Mammalian genes encoding 3'-5' exonuclease |
| 01/27/2000 | WO1999059624A3 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia |
| 01/27/2000 | WO1999059609A3 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
| 01/27/2000 | WO1999052925A9 Programmed cell death and caspase-12 |
| 01/27/2000 | WO1999051238A9 Semi-synthetic ecteinascidins |
| 01/27/2000 | WO1999047152A3 Use of dipeptidyl peptidase (dpp4) of fibroblast activating protein alpha for suppressing the malignant phenotype of cancer cells |
| 01/27/2000 | DE19932216A1 Micro and nano particles useful e.g. as carriers of medicines, and agrochemicals, absorbents for cosmetic purposes, and for separations and analysis. |
| 01/27/2000 | DE19833105A1 New N-amidinophenyl-1-carboxymethyl-4-piperidinepropanamide derivatives useful as antithrombotic, antiaggregatory, antitumor, antimetastatic, antiinflammatory and anti-osteoporosis agents |
| 01/27/2000 | CA2337771A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 01/27/2000 | CA2337517A1 Novel dna-cleaving antitumor agents |
| 01/27/2000 | CA2337407A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | CA2337305A1 Diacylhydrazine derivatives |
| 01/27/2000 | CA2337256A1 Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents |
| 01/27/2000 | CA2337231A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | CA2337179A1 Therapeutic composition based on flavonoids, intended to be used in the treatment of tomours by cytotoxic |
| 01/27/2000 | CA2337115A1 Pharmaceutical compositions comprising 2-quinolones |
| 01/27/2000 | CA2335649A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2333929A1 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | CA2333467A1 Human presenilin-associated protein |
| 01/27/2000 | CA2303062A1 Human aspartic proteases |
| 01/26/2000 | EP0974668A1 Use of adenoviral E4 reading frames to improve expression of a gene of interest |
| 01/26/2000 | EP0974058A2 20 human secreted proteins |
| 01/26/2000 | EP0973926A1 Adenoviral vectors with modified tropism |
| 01/26/2000 | EP0973916A1 Composition and method for inducing an immune response against tumour-related antigens |
| 01/26/2000 | EP0973904A1 COMPOSITIONS AND USE OF M-CSF-alpha |
| 01/26/2000 | EP0973902A1 Radioisotope concentrator methods and compositions |
| 01/26/2000 | EP0973897A1 Human tumor-associated membrane protein |
| 01/26/2000 | EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 01/26/2000 | EP0973892A2 28 human secreted proteins |
| 01/26/2000 | EP0973881A2 Mycobacterium recombinant vaccines |
| 01/26/2000 | EP0973819A1 Non-antigenic branched polymer conjugates |
| 01/26/2000 | EP0973804A2 Anti-vegf antibodies |
| 01/26/2000 | EP0973801A1 GnRH ANTAGONISTS |
| 01/26/2000 | EP0973789A1 Novel phosphate compounds and their use as medicaments |
| 01/26/2000 | EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973746A1 Substituted 3-cyano quinolines |
| 01/26/2000 | EP0973733A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 01/26/2000 | EP0973731A1 Hydroxamic acid derivatives |
| 01/26/2000 | EP0973730A1 Calcilytic compounds |
| 01/26/2000 | EP0973727A2 Activated iododerivatives for the treatment of cancer and aids |
| 01/26/2000 | EP0973554A1 Chelating agents |
| 01/26/2000 | EP0973551A2 Polymeric conjugates polyvalently presenting an agent for therapy |
| 01/26/2000 | EP0973548A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
| 01/26/2000 | EP0973541A1 Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterising cancer cells with individual properties |
| 01/26/2000 | EP0973540A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 |
| 01/26/2000 | EP0973532A1 Anti-proliferative preparations |
| 01/26/2000 | EP0973530A1 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 01/26/2000 | EP0973518A1 Semi-synthetic studies toward didemnin analogues |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973396A1 A method of treating cancer |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973390A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
| 01/26/2000 | EP0973381A2 Animal model for evaluation of vaccines |
| 01/26/2000 | EP0927030A4 Use of aryl n-substituted carboxamides to kill tumors |
| 01/26/2000 | EP0700305B1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 01/26/2000 | EP0670839B1 Process for the preparation of 9-amino camptothecin |
| 01/26/2000 | EP0626943B1 Bistriazenes as chemotherapeutic agents |
| 01/26/2000 | EP0587735B1 T cell receptor peptides as therapeutics for immune-related disease |
| 01/26/2000 | CN1242209A Traditonal Chinese medicine soft extract for anticancer and relieving pain |
| 01/26/2000 | CN1242192A Pharmaceutical composition contg. amino-acid adduct |
| 01/26/2000 | CN1242148A Xianggu mushroom tea and method for producing same |
| 01/25/2000 | US6018062 17-difluoromethylene-estratrienes |
| 01/25/2000 | US6018042 An oligonucleotide derivative capable of modulating the biosynthesis of human s-adenosylmethionine decarboxylase enzyme; antiproliferative/antitumor/antimetastasis agents |
| 01/25/2000 | US6017958 A therapeutic treatment using a methyl alkyloxy- or thio-phenyl benzoate, as potent, selective and non-toxic anti-tumor agents for treating cancer |
| 01/25/2000 | US6017948 A pharmaceutically-acceptable anticancer drug paclitaxel in non-aqueous solvent comprising n-methyl pyrrolidone, excluding dimethylacetamide or dimethyl sulfoxide |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017923 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 01/25/2000 | US6017922 Thermally stable trimetrexates and processes for producing the same |
| 01/25/2000 | US6017907 Structural analogues of vitamin D |
| 01/25/2000 | US6017904 Steroid sulphatase inhibitors |
| 01/25/2000 | US6017898 Inhibition of tumor growth by antisense oligonucleotides for IL-8 and IL-8 receptor |
| 01/25/2000 | US6017889 Metalloproteinase inhibitors |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017705 Nucleic acid molecules that codes for tumor rejection antigens; diagnosis and screening for possible presence of lymphoma, or head and neck squamous cell carcinoma, skin and mammary carcinomas |
| 01/25/2000 | US6017557 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 01/25/2000 | US6017544 Isolating stress protein-peptide complex from tumor cells previously removed from a mammal and administering the isolated stress protein-peptide complex along with a cytokine to the mammal in order to stimulate an immune response |
| 01/25/2000 | US6017540 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
| 01/25/2000 | US6017529 A purified human spermidine/spermine n1-acetyltransferase comprising the amino acid sequence of seq id no:1; diagnostic assays; prevention and treatment of cancer |
| 01/25/2000 | CA2163904C Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 01/25/2000 | CA2053231C Novel vitamin d analogues |
| 01/25/2000 | CA1340880C Cancer-related antigen-specific human immunoglobulins and human/human hybridomas having the ability to produce said human immunoglobulins |
| 01/20/2000 | WO2000003244A2 Immortalized human keratinocyte cell line |